江西省中药产业发展的同质化问题和对策研究——以江西省樟树市为例  

To Study the Homogenization Issues and Countermeasures of the Traditional Chinese Medicine Industry in Jiangxi Province:A Case Study of Zhangshu

作　　者：陈海清 谢俊俊 陈雨萍 熊乐乐 CHEN Haiqing;XIE Junjun;CHEN Yuping;XIONG Lele(Jiangxi Drug Inspection Center,Nanchang Jiangxi 330001,China;Jiangxi Institute for Drug Control,NMPA Key Laboratory of Quality Evaluation of Traditional Chinese Patent Medicine,Jiangxi Province Engineering Research Center of Drug and Medical Device Quality,Nanchang Jiangxi 330029,China)

机构地区：[1]江西省药品检查员中心,江西南昌330001 [2]江西省药品检验检测研究院,国家药品监督管理局中成药质量评价重点实验室,江西省药品与医疗器械质量工程技术研究中心,江西南昌330029

出　　处：《药品评价》2023年第10期1171-1175,共5页Drug Evaluation

基　　金：江西省药品监督管理局科研项目(2022GL14)。

摘　　要：江西省樟树市是国内唯一授予“中国药都”的县级市,樟树的中药产业是江西省中药产业发展的代表和缩影。研究樟树中药产业发展中遇到的问题和瓶颈,对于探寻江西中药产业发展的路径和方向具有重要意义。该研究以实地调研数据为基础,发现樟树中药产业主要问题是产品同质化严重;探讨了产品同质化的表现形式,分析产品同质化的影响因素及权重比例,为江西中药产业差异化发展探寻切入点和途径。Zhangshu is the only city awarded the title of"Chinese Medicine Capital"in county-level cities,it is a representative and microcosm of the traditional Chinese medicine industry in Jiangxi Province.Studying the development problems and bottlenecks of the traditional Chinese medicine industry in Zhangshu is of great significance for exploring the path and direction of the development of Jiangxi traditional Chinese medicine industry.Based on field research data,this study found that the main problem with the traditional Chinese medicine industry in Zhangshu was severe product homogenization.This study explores the manifestations of product homogenization,analyzes the influencing factors and weight ratios of product homogenization.Exploring entry points and approaches for the differentiated development of Jiangxi's traditional Chinese medicine industry.

关 键 词：中草药 中药产业 同质化 问题 对策 数据收集 江西 

分 类 号：R2-03[医药卫生—中医学] F426.72[经济管理—产业经济] F326.12